Association of Pediatric Heart Transplant Coronary Vasculopathy with Abnormal Hemodynamic Measures

Congenital Heart Disease

Volumn 6, Issue 2, 2011, Pages 128-133

  Aiyagari, Ranjit ^a   Nika, Melisa ^a   Gurney, James G ^a   Donohue, Janet E ^a   Zamberlan, Mary C ^a   King, Karen ^a   Crowley, Dennis C ^a   Gajarski, Robert J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Pediatric Transplant Coronary Vasculopathy

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; CHILD; CORONARY ARTERY DISEASE; DEATH; GRAFT SURVIVAL; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RIGHT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; RETRANSPLANTATION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TRANSPLANT CORONARY ARTERY DISEASE;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; GRAFT SURVIVAL; HEART CATHETERIZATION; HEART TRANSPLANTATION; HEMODYNAMICS; HUMANS; LOGISTIC MODELS; MICHIGAN; PULMONARY WEDGE PRESSURE; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE; YOUNG ADULT;

EID: 79953001962     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2010.00470.x     Document Type: Article

References (19)

1. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: eighth official pediatric report-2005. J Heart Lung Transplant. 2005;24:968-982.
2. Leman NR, Levi DS, Alejos JC, Wetzel GT. Predictors of graft longevity in pediatric heart transplantation. Pediatr Cardiol. 2005;26:762-767.
3. Pahl E, Zales VR, Fricker FJ, Addonizio LJ. Posttransplant coronary artery disease in children. A multicenter national survey. Circulation. 1994;90:II56-II60.
4. Mulla NF, Johnston JK, Vander Dussen L, etal. Late rejection is a predictor of transplant coronary artery disease in children. J Am Coll Cardiol. 2001;37:243-250.
5. Costello JM, Wax DF, Binns HJ, Backer CL, Mavroudis C, Pahl E. A comparison of intravascular ultrasound with coronary angiography for evaluation of transplant coronary disease in pediatric heart transplant recipients. J Heart Lung Transplant. 2003;22:44-49.
6. Di Filippo S, Semiond B, Roriz R, Sassolas F, Raboisson MJ, Bozio A. Non-invasive detection of coronary artery disease by dobutamine-stress echocardiography in children after heart transplantation. J Heart Lung Transplant. 2003;22:876-882.
7. Dipchand AI, Bharat W, Manlhiot C, Safi M, Lobach NE, McCrindle BW. A prospective study of dobutamine stress echocardiography for the assessment of cardiac allograft vasculopathy in pediatric heart transplant recipients. Pediatr Transplant. 2008;12:570-576.
8. Schubert S, Abdul-Khaliq H, Wellnhofer E, etal. Coronary flow reserve measurement detects transplant coronary artery disease in pediatric heart transplant patients. J Heart Lung Transplant. 2008;27:514-521.
9. Tona F, Caforio ALP, Montisci R, etal. Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation. 2006;114:I49-I55.
10. Maiers J, Hurwitz R. Identification of coronary artery disease in the pediatric cardiac transplant patient. Pediatr Cardiol. 2008;29:19-23.
11. Law Y, Boyle G, Miller S, etal. Restrictive hemodynamics are present at the time of diagnosis of allograft coronary artery disease in children. Pediatr Transplant. 2006;10:948-952.
12. Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988;12:334-340.
13. Kirk R, Edwards L, Aurora P, etal. Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric heart transplantation report-2008. J Heart Lung Transplant. 2008;27:970-977.
14. Raichlin E, Bae J-H, Khalpey Z, etal. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation. 2007;116:2726-2733.
15. Quinones M. Evaluation of intracardiac filling pressures. In: Klein AL, Garcia MJ, eds. Diastology: Clinical Approach to Diastolic Heart Failure. Philadelphia, Pa: Saunders/Elsevier; 2008: 181-192.
16. Ventura HO, Mehra MR, Smart FW, Stapleton DD. Cardiac allograft vasculopathy: current concepts. Am Heart J. 1995;129:791-799.
17. Hathout E, Beeson WL, Kuhn M, etal. Cardiac allograft vasculopathy in pediatric heart transplant recipients. Transpl Int. 2006;19:184-189.
18. Mancini D, Pinney S, Burkhoff D, etal. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation. 2003;108:48-53.
19. Zakliczynski M, Swierad M, Nozynski J, Maruszewski M, Zembala M. Survival benefit in heart transplant recipients who have coronary artery disease confirmed using angiography and are receiving sirolimus. Transplant Proc. 2009;41:285-288.